APA

Shao N., Yu X., Ma X., Lin W., Hao M. & Kuang H. (2018). Exenatide Delays the Progression of Nonalcoholic Fatty Liver Disease in C57BL/6 Mice, Which May Involve Inhibition of the NLRP3 Inflammasome through the Mitophagy Pathway. : Gastroenterology research and practice.

Chicago

Shao Ning, Yu Xin-Yang, Ma Xue-Fei, Lin Wen-Jian, Hao Ming and Kuang Hong-Yu. 2018. Exenatide Delays the Progression of Nonalcoholic Fatty Liver Disease in C57BL/6 Mice, Which May Involve Inhibition of the NLRP3 Inflammasome through the Mitophagy Pathway. : Gastroenterology research and practice.

Harvard

Shao N., Yu X., Ma X., Lin W., Hao M. and Kuang H. (2018). Exenatide Delays the Progression of Nonalcoholic Fatty Liver Disease in C57BL/6 Mice, Which May Involve Inhibition of the NLRP3 Inflammasome through the Mitophagy Pathway. : Gastroenterology research and practice.

MLA

Shao Ning, Yu Xin-Yang, Ma Xue-Fei, Lin Wen-Jian, Hao Ming and Kuang Hong-Yu. Exenatide Delays the Progression of Nonalcoholic Fatty Liver Disease in C57BL/6 Mice, Which May Involve Inhibition of the NLRP3 Inflammasome through the Mitophagy Pathway. : Gastroenterology research and practice. 2018.